TEFAXONE

This brand name is authorized in Nigeria.

Active ingredients

The drug TEFAXONE contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 75J73V1629 - CEFTRIAXONE
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-8887	Injection	TEFAXONE INJECTION INJ 1000 mg 1 X 1G VIAL + 1 X 10ML AMPOULE	72 RNW-PP-108754 TEFAXONE INJECTION CEFTRIAXONE 1000MG Ceftriaxone 1000mg Apr-87 Drugs Imported Products 1 X 1G VIAL + 1 X 10ML AMPOULE Prescription Only Medicine (POM) 1/2/2020 MERIT HEALTHCARE LTD, Iya-Oba House, 10 Dele Ashiru Street, Ire-Akari Estate, Isolo 8171273639 casmolar1@yahoo.com Stallion Lab Pvt Limited, C/B. 305 2 & 3 GIDC Kerala Bavla District Ahmeddabad India, India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-8887